HTN App for HTN Control and Cardiovascular Health Among African-Americans - Trial NCT06346886
Access comprehensive clinical trial information for NCT06346886 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Not yet recruiting. The study focuses on Hypertension. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Mayo Clinic
Timeline & Enrollment
N/A
Apr 01, 2024
Jul 01, 2025
Primary Outcome
Absolute Change in Systolic Blood Pressure (BP),HTN Self-Care as reported by H-SCALE(HTN Self-Care Activity Level Effects)
Summary
The purpose of this study is to test the hypertension (HTN) app-based intervention to see if
 it is more effective in improving uncontrolled HTN and HTN self-care among Africian-Americans
 from baseline to post-intervention (immediate, 3 months and 6 months post-intervention) as
 compared to the standard of care.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06346886
Non-Device Trial

